ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering – TradingView

SAN MATEO, Calif. and SINGAPORE, March 12, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals Ltd. NASDAQ:ASLN, a clinical-stage, immunology focused …

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 86% regionally and is currently trending positivepositive.


Media Trust Score100%